Informasi ini hanya untuk tujuan edukasi. Ini bukan nasihat medis. Selalu konsultasikan dengan tenaga kesehatan profesional.
Deskripsi, Dosis, Efek Samping, Kontraindikasi. Data from EMA, URPL, openFDA and other regulatory sources.
| Sertraline | Escitalopram | |
|---|---|---|
| Zat Aktif | SERTRALINE HYDROCHLORIDE | ESCITALOPRAM (ESCITALOPRAM OXALATE) |
| Kode ATC | N06AB06 | N06AB10 |
| Bentuk | TABLET, FILM COATED | — |
| Dosis | 50 mg/1 | — |
| Rute pemberian | ORAL | — |
| Produsen | Exelan Pharmaceuticals, Inc. | JUBILANT GENERICS LIMITED |
Sertraline (INN: SERTRALINE HYDROCHLORIDE, ATC N06AB06) and Escitalopram (INN: ESCITALOPRAM (ESCITALOPRAM OXALATE), ATC N06AB10) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Informasi ini hanya untuk tujuan edukasi. Ini bukan nasihat medis. Selalu konsultasikan dengan tenaga kesehatan profesional.